Renaissance Technologies (RenTech)'s VOR Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 33,011 shares of Vor Biopharma Inc. (VOR) worth $607,733, representing 0.00% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in VOR, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 128,839 shares. Largest reduction occurred in Q2 2026, reducing 95,828 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Vor Biopharma (VOR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vor Biopharma (VOR) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -95,828 | Reduce 74.38% | 33,011 | $18.41 |
| Q1 2026 | +128,839 | New Buy | 128,839 | $17.84 |
| Q4 2025 | -14,600 | Sold Out | 0 | $0.00 |
| Q3 2025 | -8,806 | Reduce 37.62% | 14,600 | $48.72 |
| Q2 2025 | -11,666 | Reduce 33.26% | 23,406 | $32.40 |
| Q1 2025 | +8,597 | Add 32.47% | 35,072 | $14.35 |
| Q4 2024 | -11,326 | Reduce 29.96% | 26,475 | $22.20 |
| Q3 2024 | +13,036 | Add 52.64% | 37,801 | $14.00 |
| Q2 2024 | +8,032 | Add 48.00% | 24,765 | $20.00 |
| Q1 2024 | +14,153 | Add 548.57% | 16,733 | $47.39 |
| Q4 2023 | +755 | Add 41.37% | 2,580 | $44.96 |
| Q3 2023 | +5 | Add 0.27% | 1,825 | $42.19 |
| Q2 2023 | +400 | Add 28.17% | 1,820 | $0.06 |
| Q1 2023 | -878 | Reduce 38.21% | 1,420 | $0.11 |
| Q4 2022 | +703 | Add 44.08% | 2,298 | $0.13 |
| Q3 2022 | +730 | Add 84.39% | 1,595 | $79.62 |
| Q2 2022 | +865 | New Buy | 865 | $99.42 |
Renaissance Technologies (RenTech)'s Vor Biopharma Investment FAQs
Renaissance Technologies (RenTech) first purchased Vor Biopharma Inc. (VOR) in Q2 2022, acquiring 865 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Vor Biopharma Inc. (VOR) for 17 quarters since Q2 2022.
Renaissance Technologies (RenTech)'s largest addition to Vor Biopharma Inc. (VOR) was in Q1 2026, adding 128,839 shares worth $2.3 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 33,011 shares of Vor Biopharma Inc. (VOR), valued at approximately $607,733.
As of the Q2 2026 filing, Vor Biopharma Inc. (VOR) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Vor Biopharma Inc. (VOR) was 128,839 shares, as reported at the end of Q1 2026.